alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No. 02-2212

CHARLES M. PERSSON, Plaintiff - Appellant, versus CREDIT BUREAU OF SOUTHERN VIRGINIA, INCORPORATED, Defendant - Appellee, and AMERICREDIT FINANCIAL SERVICES, INCORPORATED; REGIONAL ACCEPTANCE CORPORATION; VICTORY NISSAN OF RICHMOND, INCORPORATED, Parties in Interest. Appeal from the United States District Court for the Eastern District of Virginia, at Richmond. Richard L. Williams, Senior District Judge. (MC-02-8-3) Submitted: November 21, 2002 Decided: November 27, 2002 Before NIEMEYER, WILLIAMS, and TRAXLER, Circuit Judges. Dismissed by unpublished per curiam opinion. Charles M. Persson, Appellant Pro Se.2 Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).

PER CURIAM: Charles Persson appeals from orders of the District Court for the Eastern District of Virginia denying Persson’s requests for the issuance of a subpoena relating to a complaint he filed in the District Court for the Western District of Virginia. He also asks this court to direct the Western District to hold his case in abeyance pending resolution of this appeal. Our review of the record and the pertinent district court dockets reveals that Persson’s underlying complaint was dismissed with prejudice in the Western District following a settlement reached by the parties. This action renders Persson’s claim be fore this court no longer justiciable. Accordingly, we deny Persson’s motion to direct that his case be held in abeyance, and we dismiss the appeal as moot. See Leonard v. Hammond , 804 F.2d 838, 842 (4th Cir. 1986). We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

DISMISSED
June 30, 2016

JUDGMENT

The Fourteenth Court of Appeals

ELBERT DAVIS, Appellant

NO. 14-15-00059-CV V.

EBBIE LOVING D/B/A A-K-A BAIL BONDS, Appellee

________________________________

This cause, an appeal from the judgment in favor of appellee, Ebbie Loving 

d/b/a A-K-A Bail Bonds, signed, October 31, 2014, was heard on the transcript of 

the record. We have inspected the record and find error in the judgment. We 

therefore order the judgment of the court below REVERSED and REMAND the 

cause for proceedings in accordance with the court’s opinion.

We further order that all costs incurred by reason of this appeal be paid by 

appellee, Ebbie Loving d/b/a A-K-A Bail Bonds.

We further order this decision certified below for observance.
<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> 9
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               DEC-31-1998
<CASH>                                       1,547,464
<INT-BEARING-DEPOSITS>                      14,823,967
<FED-FUNDS-SOLD>                                     0
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                  8,282,450
<INVESTMENTS-CARRYING>                     147,249,237
<INVESTMENTS-MARKET>                       148,403,448
<LOANS>                                    141,988,993
<ALLOWANCE>                                  1,716,790
<TOTAL-ASSETS>                             328,608,883
<DEPOSITS>                                 238,312,941
<SHORT-TERM>                                         0
<LIABILITIES-OTHER>                          1,532,008
<LONG-TERM>                                 42,009,880
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        41,972
<OTHER-SE>                                  46,712,082
<TOTAL-LIABILITIES-AND-EQUITY>             328,608,883
<INTEREST-LOAN>                             10,082,633
<INTEREST-INVEST>                           10,547,777
<INTEREST-OTHER>                               684,273
<INTEREST-TOTAL>                            21,314,683
<INTEREST-DEPOSIT>                           9,747,271
<INTEREST-EXPENSE>                          12,218,809
<INTEREST-INCOME-NET>                        9,095,874
<LOAN-LOSSES>                                 (130,630)
<SECURITIES-GAINS>                                   0
<EXPENSE-OTHER>                              7,606,817
<INCOME-PRETAX>                              2,149,337
<INCOME-PRE-EXTRAORDINARY>                   2,149,337
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 1,397,300
<EPS-PRIMARY>                                     0.34
<EPS-DILUTED>                                     0.34
<YIELD-ACTUAL>                                    7.05
<LOANS-NON>                                  2,084,000
<LOANS-PAST>                                         0
<LOANS-TROUBLED>                                94,000
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                             1,885,021
<CHARGE-OFFS>                                   37,451
<RECOVERIES>                                         0
<ALLOWANCE-CLOSE>                            1,716,940
<ALLOWANCE-DOMESTIC>                         1,716,940
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0
        

</TABLE>
EXHIBIT 13



FREEGOLD VENTURES LIMITED

(the Company)



Request for Financial Statements



In accordance with National Instrument 51-102 Continuous Disclosure Obligations,a reporting issuer isrequired to send annually a request form to registered holders and beneficial owners of its securities to enable the holders and owners to request a copy of the Companys annual financial statements and related MD&A and/or interim financial statements and related MD&A, in accordance with the procedures set out in National Instrument 54-101 Communication with Beneficial Owners of Securities of a Reporting Issuer.  If you wish to receive either or both of the financial statements, please complete and return this form to our offices.



COMPLETE AND RETURN THIS FORM TO:



FREEGOLD VENTURES LIMITED

2303 West 41st Avenue

Vancouver, BC  V6M 2A3

Facsimile:  604-685-6550



________  I wish to receive Annual Financial Statements and related MD&A



________  I wish to receive Interim Financial Statements and related MD&A



________  I wish to receive both Annual Financial Statements and related MD&As





NAME:

TELEPHONE:





ADDRESS:

FACSIMILE:





EMAIL:





Please note that a request form will be mailed each year.  If you wish to receive such materials, a request form must be returned to the Company each year to receive the Annual and Interim Financial Statements and related MD&As.



I confirm that I am a registered / beneficial shareholder of the Company





SIGNATURE OF SHAREHOLDER:



DATE:





CUSIP:  356455 10 5
EXHIBIT
32.1





CERTIFICATION
PURSUANT TO


18
U.S.C. SECTION 1350


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002





The
undersigned, Eli Gonen, President, Chief Executive Officer and Director of
Cardio Vascular Medical Corp. (the “Company”), certifies, under the standards
set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge, the
Quarterly Report on Form 10-Q of the Company for the quarter ended
September  30, 2009, fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained
in that Form 10-Q fairly presents, in all material respects, the financial
condition and results of operations of the Company.




Date:
October 30, 2009





By:
                  /s/ Eli GonenName:
                  Eli
      GonenTitle:
                  President,
      Chief Executive Officer and
                    Director
      (Principal Executive
Officer)




A signed
original of this written statement required by Section 906 has been provided to
the Company and will be retained by the Company and furnished to the Securities
and Exchange Commission or its staff upon request.
Exhibit
32.1



CERTIFICATION
OF CHIEF EXECUTIVE OFFICER

PURSUANT
TO 18 U.S.C. SECTION 1350

AS
ADOPTED PURSUANT TO

SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002



In
connection with the Annual Report of Immune Therapeutics, Inc. (the “Company”) on Form 10-K/A for the period
ended December 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I,
Kevin Phelps, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002, that:



| | (1) | The
    Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended;
    and                   
| | --- | ------------------------------------------------------------------------------------------------------------------------------------------------------------
| |     |                                                                                                                                                             
| | (2) | The
    information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
    of the Company.



|Date:
    August 28, 2020 | By: | /s/
    Kevin Phelps       
|------------------------- | --- | ---------------------------
|                          |     | Kevin
    Phelps           
|                          |     | Chief
    Executive Officer
Exhibit 32.1

**CERTIFICATION PURSUANT TO 18 U.S.C. 1350,**

**AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEYACT OF 2002**

In connection with the quarterlyannual report of EZJR, Inc.(the “Company”) on Form 10-Q for the three months ended June 30, 2014, as filed with the Securities and Exchange Commissionon the date hereof (the “Report”), I, Edward Zimbardi, Chief Executive Officer of the Company, certify, to the bestof my knowledge and belief, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of2002, that:

i.	The Report fully complieswith the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and

ii.	The information containedin the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 13, 2014

 

 

/s/ Edward Zimbardi	

Name: Edward Zimbardi

Title: Chief Executive Officer

(Principal Executive Officer)
[Federal Register Volume 89, Number 202 (Friday, October 18, 2024)]
[Notices]
[Pages 83895-83896]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-24058]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Bat Immunology Network Research 
Projects (R01 Clinical Trial Not Allowed) and Bat Immunology Network 
Research Resource Program (U24 Clinical Trial Not Allowed).
    Date: November 25-26, 2024.
    Time: 10:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Rockville, MD 
20892.
    Meeting Format: Video Assisted Meeting.
    Contact Person: Sandip Bhattacharyya, Ph.D., Scientific Review 
Officer, Scientific

[[Page 83896]]

Review Program, Division of Extramural Activities, National 
Institute of Allergy and Infectious Diseases, National Institutes of 
Health, 5601 Fishers Lane, MSC 9834, Rockville, MD 20892, 
<a href="/cdn-cgi/l/email-protection#fb889a959f928bd599939a8f8f9a98939a8982829abb959293d59c948d"><span class="__cf_email__" data-cfemail="d6a5b7b8b2bfa6f8b4beb7a2a2b7b5beb7a4afafb796b8bfbef8b1b9a0">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: October 11, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-24058 Filed 10-17-24; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit 32.1 - President Certification (Section 906)

                        CERTIFICATION PURSUANT TO
                         18 U.S.C. SECTION 1350,
                         AS ADOPTED PURSUANT TO
             SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


I am the Principal Executive Officer and Principal Financial Officer of
EZJR, Inc., a Nevada corporation (the "Company").  I am delivering this
certificate in connection with the Form 10-Q of the Company for the quarter
ended December 31, 2010 and filed with the U. S. Securities and Exchange
Commission ("Form 10-Q").

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002, I hereby certify that, to the best of my
knowledge, the Form 10-Q fully complies with the requirements of Section
13(a) or Section 15(d) of the Securities Exchange Act of 1934 and that the
information contained in the Form 10-Q fairly presents, in all material
respects, the financial condition and results of operations of the Company.


   /s/ T J Jesky
----------------------------------
       T J Jesky
Its:   Principal Executive Officer
       Principal Financial Officer



Date  February 11, 2011
      -----------------

<PAGE>
United States 

Office of 

Personnel Management 

The Federal Government’s Human Resources Agency

Benefits Administration Letter 

Number: 09-403 Date: September 17, 2009 

Subject: 2009 Federal Benefits Open Season: Ordering and Distributing Materials

This is the third Benefits Administration Letter (BAL) in our series of 2009 Federal 

Benefits Open Season BALs. This BAL (09-403) provides instructions for ordering and 

distributing Open Season materials including program-specific materials. You can find 

previously issued Open Season BALs at www.opm.gov/retire/pubs/bals/bal09.asp. 

We divided this BAL into five sections to provide information regarding your 

responsibilities for the upcoming Open Season. 

• Attachment 1: Easy to Use Chart for Ordering and Distributing FSAFEDS, 

FEDVIP, and FEHB Materials 

• Attachment 2: Plan Contacts for Ordering Federal Employees Dental and Vision 

Insurance Program (FEDVIP) Brochures 

• Attachment 3: Plan Contacts for Ordering Federal Employees Health Benefits 

(FEHB) Brochures 

• Attachment 4: FEHB Plan Contacts Regarding Enrollment 

• Attachment 5: Open Fee-For-Service FEHB Plan Contacts for Ordering Audio 

We are still concerned that Open Season materials are not reaching all Federal employees 

and field offices. Each year we continue to hear from regional and field offices who have 

not received Open Season material from their headquarters and from FEHB plans who 

tell us they receive brochure shipments, unopened, that have been returned from agency 

distribution points. You must ensure Open Season materials reach your employees 

and your field offices. Employees need these materials to aid in their decision making. 

This year’s Federal Benefits Open Season will run from Monday, November 9 through 

Monday, December 14, 2009. 

The Federal Employees’ Group Life Insurance (FEGLI) Program and the Federal Long 

Term Care Insurance Program (FLTCIP) are not participating in this year’s Federal 

Benefits Open Season. 

1
If you have specific questions about the Open Season, please contact your agency’s 

benefits officer. If you do not know who this person is, please go to 

http://apps.opm.gov/abo/ where you will find a list of agencies and their Headquarters 

Benefits Officers. 

We look forward to working with you in the upcoming 2009 Federal Benefits Open 

Season for enrollment for the 2010 Plan Year. As always, we encourage you and your 

employees to visit http://www.opm.gov/insure. 

Sincerely, 

 Kathleen M. McGettigan 

Deputy Associate Director 

Center for Retirement and Insurance Services 

2
---

---

EXHIBIT 15.3

CONSENT OF INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by
reference into the Registration Statements on Form S-8 (File Nos. 333-14238, 333-12146,
333-09840, 333-109874 and 333-118930) and Form F-3 (file no. 333-110681) of Retalix Ltd.
(the Company) of our report dated January 23, 2005 on the financial statements
of Cell-Time, Ltd., as of December 31, 2004 and 2003 and for the year ended December 31,
2004 and the period from March 25, 2003 to December 31, 2003, which appears in this Annual
Report of the Company on Form 20-F as of and for the year ending December 31, 2004.

Tel- Aviv, IsraelMarch 21, 2005

| |  | /s/ KOST FORER GABBAY & KASIERER
A Member of Ernst & Young Global
| |  | -----------------------------------------------------------------



---

---
## F IRST 

## D ISTRICT 

## C OURT OF 

## A PPEAL 

## S TATE OF 

## F LORIDA

_____________________________ No. 1D 18

- 2818

_____________________________ G ERARD L. B ROOKINS , Petitioner ,

v.
S TATE OF F LORIDA , Respondent

.

_____________________________

Petition for Writ of Habeas Cor pus

— Original Jurisdiction

.

December 7, 2018

P ER C URIAM

. D ISMISSED

. See Baker v. State , 878 So. 2d 1236 (Fla. 2004).
W OLF , M AKAR , and M.K. T HOMAS , JJ., concur

.

_____________________________ Not final until disposition of any timely and authorized motion under Fla. R. App. P. 9.330 or 9.331

.

_____________________________2 Gerard L. Brookins, pro se , Petitioner

. Pamela Jo Bondi, Attorney General, Tallahassee , for Respondent

.
Exhibit 10.5.2

EMPLOYMENT AGREEMENT  AMENDMENT NO. 2

THIS AMENDMENT NO.2 (this "Amendment") dated September 15, 2004 is made to the EMPLOYMENT AGREEMENT dated as of August 14, 2000 (as amended by
Amendment No.1 dated February 13, 2002, the "Agreement") by and between Advanstar, Inc. (the "Company") and James M. Alic ("Executive").

WHEREAS, the parties to the Agreement seek to modify certain terms of the Agreement to the extent described in this Amendment;

THEREFORE, in consideration of the mutual promises contained herein, and for other good and valuable consideration, intending to be legally bound, the
Company and Executive hereby agree as follows:



For U.S. Mail

For Private CourierJames M. Alic
P.O. Box G
Ludlow, VT 05149

James M. Alic
172 Summit View Road
Ludlow, VT 05149


This Amendment is effective as of the date indicated above. Except to the extent amended by this Amendment, the Agreement is affirmed and remains in full force and effect.

---



IN WITNESS WHEREOF, the parties have duly signed this Amendment as of the day and year first written above.

|ADVANSTAR, INC. |  | JAMES M. ALIC
|--------------- |  | -------------

|    |  |                                          |  |                 
|--- |  | ---------------------------------------- |  | ----------------
|By: |  | /s/JOE LOGGIAName: Joe Loggia
Title: CEO |  | /s/JAMES M. ALIC

2

---



QuickLinks
Exhibit 32.1  CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  In connection with the Quarterly Report of AI Document Services, Inc. (the Company) on Form 10-Q for the period ended June 30, 2013 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Mark Cohen, Chief Executive and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:  1. The Report fully complies with requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and  2. The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.   /s/ Mark Cohen Mark Cohen Title: President and Chief Financial Officer  August 14, 2013
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Small Business Administration

          - [Disaster Declaration #20711 and #20712; GEORGIA Disaster Number GA-20013]

# AGENCY:

U.S. Small Business Administration.

# ACTION:

Amendment 5.

# SUMMARY:

                        This is an amendment of the Presidential declaration of a major                               ( print page 83934)                            disaster for the State of Georgia (FEMA-4830-DR), dated 09/30/2024.                    

*Incident:*                         Hurricane Helene.                    

*Incident Period:*                         09/24/2024 and continuing.                    

# DATES:

Issued on 10/11/2024.

*Physical Loan Application Deadline Date:*                         11/29/2024.                    

*Economic Injury (EIDL) Loan Application Deadline Date:*                         06/30/2025.                    

# ADDRESSES:

*Visit the MySBA Loan Portal at https://lending.sba.gov*                         to apply for a disaster assistance loan.                    

# FOR FURTHER INFORMATION CONTACT:

Alan Escobar, Office of Disaster Recovery & Resilience, U.S. Small Business Administration, 409 3rd Street SW, Suite 6050, Washington, DC 20416, (202) 205-6734.

# SUPPLEMENTARY INFORMATION:

The notice of the President's major disaster declaration for the State of Georgia, dated 09/30/2024, is hereby amended to include the following areas as adversely affected by the disaster:

*Primary Counties (Physical Damage and Economic Injury Loans):*                     Brantley, Fulton.                

*Contiguous Counties (Economic Injury Loans Only):*

Georgia: Carroll, Cherokee, Clayton, Cobb, Coweta, DeKalb, Douglas, Fayette, Forsyth, Gwinnett.

All other information in the original declaration remains unchanged.

(Catalog of Federal Domestic Assistance Number 59008)

Rafaela Monchek,

Deputy Associate Administrator, Office of Disaster Recovery & Resilience.

[FR Doc. 2024-24174 Filed 10-17-24; 8:45 am]

BILLING CODE 8026-09-P